Where can I listen to this podcast?

This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Halteres Presents

Claim This Podcast

by Halteres Associates

5.0(8 reviews)

38 episodes

Updated Weekly

Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

Halteres Presents is an award-winning, brand-agnostic interview podcast designed to unbiasedly highlight the happenings within the diagnostics industry. In each episode, founding partner Mickey Urdea and managing partner Rich Thayer interview an expert who brings their own unique perspective to an industry topic. https://youtu.be/OmbeM2uGkHo Halteres Associates is a leading bioscience consultancy with extensive, long-term, direct operating experience in a broad spectrum of areas of expertise, including diagnostics, medical devices, therapeutics, research reagents, and bioscience tools.

Language

🇺🇲

Publishing Since

3/3/2023

Visit Website View on Apple Podcasts RSS Feed

2 verified contact emails on file for Halteres Presents

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

February 3, 2026

BONUS: Live from HLTH 2025's "Diagnostics Zone"!

On this bonus episode of "Halteres Presents", host Mickey Urdea is recording live from the first-ever <a href="https://hlth.com/events/usa/focus-area/diagnostics/" target="_blank" rel="noopener noreferer">"Diagnostics Zone"</a> at HLTH 2025 in Las Vegas! Among the many old colleagues and new faces we got to meet up with and learn from, we had the opportunity to chat with two very interesting exhibitors: <a href="https://moleculartestinglabs.com/" target="_blank" rel="noopener noreferer">Molecular Testing Labs</a> and <a href="https://otofertility.com/" target="_blank" rel="noopener noreferer">OTO Fertility</a>. From Molecular Testing Labs, Mickey spoke with their Chief Commercial Officer <a href="https://moleculartestinglabs.com/james-york-2/" target="_blank" rel="noopener noreferer">James York</a> about their "tailored solutions for diverse markets" approach, and from OTO Fertility, Mickey spoke with their CEO Caleb Evans about how their <a href="https://otofertility.com/oto-fertility-tech-launch-ai-biosensor-ces/" target="_blank" rel="noopener noreferer">wearable device</a> tracks more than fifty biometric markers to help users track their own optimal fertility in harmony with their doctors' care. Please enjoy this bonus episode of "Halteres Presents". James York is a graduate of East Tennessee State University where he majored in Exercise Physiology and prepared for medical school. Even though his interest was always focused on medicine and science, his first career position was a trader of equities and options on the Southwest Securities Trading Floor. Desiring to enter the healthcare sector and return to his roots, he leveraged his experience from the trading floor to start capitalizing, managing, operating, and making markets in various healthcare companies. James was involved in medical devices, intra-operative neuromonitoring, clinical research, networking, pharmacies, and laboratories. He has had many roles within each company including VP of Sales, President, and CEO – for companies both private and public. Caleb Evans is a health-tech entrepreneur and the CEO & Founder of OTO Fertility, a breakthrough biometric wearable and AI platform transforming reproductive care. With a background in biochemistry, digital health, and nonprofit leadership, Caleb has scaled organizations across sectors, from EMR software to fertility clinics. His mission with OTO is to apply elite biometric science to family-building, creating a new standard of care for women and couples on their path to parenthood. This episode of "Halteres Presents" is brought to you by the UC San Diego Division of Extended Studies, where courses are designed for professionals looking to deepen their expertise in the biotech space. Their core course, In Vitro Diagnostics Product Development, offers a practical, end-to-end look at taking an IVD product from concept to regulatory approval. You’ll learn about product requirements, assay development, instrumentation, risk analysis, and key clinical and regulatory considerations. Learn more about the In Vitro Diagnostics Product Development course <a href="https://extendedstudies.ucsd.edu/courses/in-vitro-diagnostics-product-development-biol-40244">⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠</a>. You can also broaden your skills with their Precision Medicine and Companion Diagnostics course, which covers biomarker-driven development, CDx/therapeutic co-development, and the expanding role of precision medicine. Learn more about the Precision Medicine and Companion Diagnostics course <a href="https://extendedstudies.ucsd.edu/courses/precision-medicine-and-companion-diagnostics-biol-40398.">⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠</a>. Use our exclusive discount code HALTERES10 at checkout for 10% off the price of your enrollment. Advance your diagnostics career with UC San Diego Extended Studies - your next step in biotech starts here. Learn more about Halteres Associates <a href="https://halteresassociates.com/">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a>.

January 13, 2026

Ep. 407: "The Value of a Molecular Cancer Signal of Origin" with Dr. Eric Klein

On this episode of "Halteres Presents", hosts Mickey Urdea and Rich Thayer are sitting down with Eric A. Klein, MD, to get his perspective on the value of a molecular cancer signal of origin in guiding targeted diagnostic evaluations based on his real-world experience overseeing GRAIL's clinical development program spanning 9 clinical trials and diverse populations, including those with occupational exposure, and more than 350,000 Galleri tests run. He also opines on what could make multi-cancer early detections tests more widely adopted and how to broaden the definition of clinical utility for reimbursement in MCED testing. Please enjoy this episode of "Halteres Presents". Eric A. Klein, MD is a Distinguished Scientist at GRAIL. Previously he served as the Andrew C. Novick Distinguished Professor and Chair of the Glickman Urological and Kidney Institute and Lerner College of Medicine of the Cleveland Clinic, where he was also a member of the Department of Cancer Biology of the Cleveland Clinic Lerner Research Institute, the Taussig Cancer Institute, and the Genitourinary Malignancies Program in the Case Comprehensive Cancer Center. Dr. Klein was a Fellow in the Distinguished Careers Institute at Stanford University in 2022 and joined GRAIL in 2023. His recent work has focused on the clinical development of multicancer early detection tests.

January 6, 2026

Ep. 406: "The Future of Non-Instrumented, One-Time-Use Tests" with Patrick Vaughan, PhD

On this episode of "Halteres Presents", hosts Mickey Urdea and Rich Thayer are sitting down with Patrick Vaughan, PhD, the Chief Operating Officer of DCN Dx, to discuss the latest advances in lateral flow assays, including innovations in reagents, antibodies, and nucleic acid LFA formats, as well as what it will take for broader adoption of rapid point-of-care testing in rural and underserved settings. Dr. Vaughan also provides valuable industry insight on the regulatory and payment challenges facing developers of new LFA tests. Please enjoy this episode of "Halteres Presents". Patrick Vaughan has over 20 years of experience in the Biotech field. Patrick has served as the Chief Operating Officer at DCN Diagnostics since September 2015. Prior to this, he was the Vice President of R&D at Trinity Biotech plc from 2003 to 2015. Patrick also founded and served as the Chief Scientific Officer of HiberGen Ltd from 1999 to 2003. Before that, he worked as a Senior Research Scientist at Enterprise Ireland & University College Cork, Ireland (UCC) from 1994 to 2000. Patrick started their career as a Post Doctoral Fellow at Institut Jacque Monod from 1992 to 1994 and as a Post Graduate at the Imperial Cancer Research Fund from 1988 to 1992. Patrick Vaughan obtained a Bachelor of Science degree in Biochemistry from the University College Cork from 1984 to 1988. Patrick then pursued further education and completed their PhD in Biochemistry at King's College London from 1988 to 1992. This episode of "Halteres Presents" is brought to you by the UC San Diego Division of Extended Studies, where courses are designed for professionals looking to deepen their expertise in the biotech space. Their core course, In Vitro Diagnostics Product Development, offers a practical, end-to-end look at taking an IVD product from concept to regulatory approval. You’ll learn about product requirements, assay development, instrumentation, risk analysis, and key clinical and regulatory considerations. Learn more about the In Vitro Diagnostics Product Development course <a href="https://extendedstudies.ucsd.edu/courses/in-vitro-diagnostics-product-development-biol-40244">⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠</a>. You can also broaden your skills with their Precision Medicine and Companion Diagnostics course, which covers biomarker-driven development, CDx/therapeutic co-development, and the expanding role of precision medicine. Learn more about the Precision Medicine and Companion Diagnostics course <a href="https://extendedstudies.ucsd.edu/courses/precision-medicine-and-companion-diagnostics-biol-40398.">⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠</a>. Use our exclusive discount code HALTERES10 at checkout for 10% off the price of your enrollment. Advance your diagnostics career with UC San Diego Extended Studies - your next step in biotech starts here. Learn more about Halteres Associates <a href="https://halteresassociates.com/">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a>.

38 total episodes available

Deep-dive analytics for Halteres Presents

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Halteres Presents?: Halteres Presents is an award-winning, brand-agnostic interview podcast designed to unbiasedly highlight the happenings within the diagnostics industry. In each episode, founding partner Mickey Urdea and managing partner Rich Thayer interview an expert who brings their own unique perspective to an industry topic.

https://youtu.be/OmbeM2uGkHo

Halteres Associates is a leading bioscience consultancy with extensive, long-term, direct operating experience in a broad spectrum of areas of expertise, including diagnostics, medical devices, therapeutics, research reagents, and bioscience tools.
How often does this podcast release new episodes?: This podcast updates weekly.
Where can I listen to this podcast?: This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Information about guest appearances is not available.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.